COMMUNIQUÉS West-GlobeNewswire

Daxor Corporation to Exhibit at the Society for Critical Care Medicine 48th Congress
13/02/2019
New Research Abstracts Scheduled for Presentation on Daxor’s BVA-100 ® NEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and [...]
International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury
13/02/2019
CARLSBAD, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]
VistaGen Therapeutics Receives Notice of Allowance for U.S. Patent for Treatment of Depression with PH10
13/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central [...]
Tauriga Sciences Inc. Includes the Phrase “DRUG TEST SAFE” on Back-Side Graphic Design of Each Individual Tauri-Gum™ Pack
13/02/2019
New York, NY, Feb. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
Integra LifeSciences Launches the Integra® Panta® 2 TTC Arthrodesis Nail System
13/02/2019
PLAINSBORO, N.J., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the launch of the Integra® Panta® 2 TTC [...]
Medexus Pharmaceuticals Schedules Third Quarter Fiscal 2019 Conference Call
13/02/2019
Retains Crescendo Communications for Investor Relations Services Conference call to be held at 4:30 PM Eastern Time on Monday, February 25, 2019 MONTREAL, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. ( [...]
Poseida Therapeutics Announces Notice of Allowance for New Patents and Registration of New Trademarks
13/02/2019
Key Patent Covers Manufacture of Therapeutic Products Containing a High Percentage of T Stem Cell Memory Cells SAN DIEGO, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a clinical-stage biopharmaceutical [...]
Calabasas Behavioral Health and BrainsWay Host “After the Smoke Clears”
13/02/2019
Free Mental Health Event to Help Los Angeles County Cope with Recent Wildfires and Mass Shooting CALABASAS, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Calabasas Behavioral Health , a leading mental health service [...]
MacroGenics to Participate in Guggenheim Healthcare Talks Idea Forum
13/02/2019
ROCKVILLE, MD, Feb. 13, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Sen-Jam Pharmaceutical Underscores the Urgent Need to Revolutionize Pain Management and End the Opioid Epidemic at the 2019 StartUp Health Festival
13/02/2019
HUNTINGTON, N.Y., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Sen-Jam Pharmaceutical , a therapeutic company focused on bringing relief to the opioid crisis, was delighted to present at the 2019 StartUp Health Festival, the [...]
Inovalon to Present at Morgan Stanley Technology, Media & Telecom Conference
13/02/2019
BOWIE, Md., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D [...]
VIVUS to Host Fourth Quarter and Full Year Business Update and Financial Results Conference Call on Tuesday, February 26, 2019
13/02/2019
CAMPBELL, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it will report financial results and provide a business update for the fourth quarter and full year of 2018 after the [...]
PSI Ramps Up its Executive Leadership Team
13/02/2019
New Roles Align the Company to Long-Term Strategy of Improving the Delivery of Healthcare ARLINGTON, Va., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Planned Systems International, Inc. (PSI), a leading provider of Health IT [...]
Auxly Bolsters Management Team
13/02/2019
VANCOUVER, British Columbia, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to announce the appointments of Brian Schmitt as Chief Financial Officer, [...]
Summit Doses First Patient in Phase 3 Clinical Trials of Precision Antibiotic Ridinilazole for C. Difficile Infection
13/02/2019
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Doses First Patient in Phase 3 Clinical Trials of Precision Antibiotic Ridinilazole for C. Difficile Infection Trials Aim to Show Superiority of Ridinilazole [...]
Emerald Health Therapeutics Announces Completion of Pure Sunfarms CAD$20 Million Credit Facility with Bank of Montreal and Farm Credit Canada
13/02/2019
VICTORIA, British Columbia, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) today announced that its 50%-owned joint venture for large-scale, low-cost, high- [...]
XOMA Receives $5.5 Million Payment from Rezolute
13/02/2019
EMERYVILLE, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today it has received a $5.5 million payment from Rezolute, Inc., related to the Companies’ 2017 license agreement, as most [...]
ContraFect Announces Oral Presentation at the 2019 Gordon Research Conference on Mechanisms and Application: Realizing the Potential of Antimicrobial Host Defense Peptides for Human and Veterinary Medicine
13/02/2019
YONKERS, N.Y., Feb. 13, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]
Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation Formulations
13/02/2019
Issuance of new patents strengthens the intellectual property around Melt Pharmaceuticals’ flagship drug candidate and potential label extensions SAN DIEGO and BOSTON, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Melt [...]

Pages